Advisory: Alert wrongly tagged to Horizons Psychedelic Stock Index ETF withdrawn
An alert on Algernon Pharmaceuticals receiving feedback from
U.S. FDA for a DMT clinical research program was inadvertently
tagged to the Horizons Psychedelic Stock Index ETF PSYK.NLB
and has been withdrawn. There will be no substitute.
STORY_NUMBER: FWN2N40SL
STORY_DATE: 17/05/2021
STORY_TIME: 11:11:30
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement